LB Pharmaceuticals, Inc. engages in the research and development of novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its product pipeline includes LB-102, is a Phase 3-ready oral, small molecule for the treatment of acute schizophrenia, defined as a sudden and severe episode of psychotic symptoms, characterized by hallucinations, delusions, and other positive symptoms. The company was founded by Vince Grattan and Zachary Prensky in 2015 and is headquartered in New York.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
27
Frequently Asked Questions
What is Market Cap of LB Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. LB Pharmaceuticals Inc market cap is $1.15B.
What is the 52-week high for LB Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. LB Pharmaceuticals Inc 52 week high is $41.33 as of August 03, 2026.
What is the 52-week low for LB Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. LB Pharmaceuticals Inc 52 week low is $13.36 as of August 03, 2026.
What is LB Pharmaceuticals Inc stock price today?
LB Pharmaceuticals Inc stock price today is $40.08.
What was LB Pharmaceuticals Inc stock price yesterday?
LB Pharmaceuticals Inc stock price yesterday was $40.90.
What is the PE ratio of LB Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. LB Pharmaceuticals Inc's P/E ratio is -26.98.
What is the Price-to-Book ratio of LB Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. LB Pharmaceuticals Inc P/B ratio is 3.0349.
What is the 50-day moving average of LB Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. LB Pharmaceuticals Inc 50-day moving average is $31.32.
How many employees does LB Pharmaceuticals Inc have?
